ArticleJournal of clinical hypertension (Greenwich, Conn.)2026
Associations of High-Sensitivity Cardiac Troponin and N-Terminal Pro-B-Type Natriuretic Peptide With Echocardiographic Features in Patients With Hypertension.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Letter to the Editor Regarding: "Associations of High-Sensitivity Cardiac Troponin and N-Terminal Pro-B-Type Natriuretic Peptide With Echocardiographic Features in Patients With Hypertension".Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
High-sensitivity cardiac troponin T (hs-cTnT) and/or N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels are associated with left ventricular structure and function in general populations, however, evidence regarding their relationship with multidimensional echocardiographic features in patients with hypertension remains limited. Hypertensive adults (aged ≥18 years) from a multicenter prospective cohort who underwent echocardiography from 2017 to 2020 were included in this study. Associations of serum hs-cTnT and NT-proBNP, alone and combined, with echocardiographic features were evaluated in multivariable-adjusted models. Among a total of 1803 hypertensive participants (mean age, 51.0 ± 11.9 years; 29.7% women), the median levels of hs-cTnT and NT-proBNP were 5.13 ng/L (IQR 3.68, 7.30) and 32.80 ng/L (IQR 17.85, 59.25), respectively. Participants in the highest hs-cTnT tertile showed greater left ventricular and atrial remodeling and higher flow velocity than those in the lowest tertile, including mean increases of 0.59 mm in left ventricular end-diastolic diameter (95% CI 0.02-1.16), 2.78 g/m
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.